Fibromuscular dysplasia differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


==Differentiating X from other Diseases==
==Differentiating X from other Diseases==
*[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
*Fibromuscular dysplasia must be differentiated from [[atherosclerotic vascular disease]].. Patients with atherosclerosis often have multiple [[atherosclerotic risk factors]], whereas most individuals with FMD are younger and have fewer risk factors.
[[Atherosclerosis]] usually involves the [[ostial]] or [[proximal]] [[segment]] of the [[arteries]], whereas FMD involves the middle or distal segment. In addition, the "string of beads" appearance is unique to FMD. Thus, atherosclerotic disease and FMD can typically be distinguished radiographically.
*There have been reports of [[Ehlers-Danlos]] Type IV being associated with medial fibroplasia. This should be suspected in patients who have multiple [[aneurysms]] in addition to the usual angiographic findings of FMD.
[[Ehlers-Danlos]] may occur in the absence of any prior bleeding manifestations. If this disease is suspected, a skin biopsy should be obtained and sent for [[fibroblast]] [[culture]].
*Multisystem involvement is observed in both [[vasculitis]] and FMD. Those with FMD generally will not have associated [[anemia]], [[thrombocytopenia]], or abnormalities of [[acute phase reactants]]. An exception is in the setting of an [[acute infarction]].
[[Large vessel vasculitis]] may occur in the absence of changes in [[acute phase reactants]] in up to 40% of cases. If histologic proof of FMD or [[inflammation]] is not available, distinguishing these entities may at times be difficult because the angiographic appearance can be similar, especially if the intimal fibroplasia is of the multivessel type.
*Segmental arterial mediolysis is a poorly understood condition characterized by [[spontaneous dissection]](s), [[occlusion]], or [[aneurysm]] formation, which may be difficult to differentiate from FMD. Similar to FMD, segmental arterial mediolysis is a noninflammatory, nonatherosclerotic arterial disease.  A definitive diagnosis of segmental arterial mediolysis requires tissue examination. This lesion of segmental arterial mediolysis is characterized by the [[vacuolar degeneration]] of [[smooth muscle cells]].
 
*Differential diagnosis of FMD Involving the [[[coronary arteries]], are cocaine vasculitis, [[coronary vasospasm]], and atherosclerotic plaque.
 
other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
*[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
*[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].


*As [disease name] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].
*As [disease namr e] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].


===Preferred Table===
===Preferred Table===

Revision as of 03:33, 16 June 2018

Fibromuscular dysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fibromuscular dysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiorgram

X-ray

CT

MRI

Arteriography

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Management Guidelines

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

ASA/ACCF/AHA Guideline Recommendations

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries

Case Studies

Case #1

Fibromuscular dysplasia differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fibromuscular dysplasia differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fibromuscular dysplasia differential diagnosis

CDC on Fibromuscular dysplasia differential diagnosis

Fibromuscular dysplasia differential diagnosis in the news

Blogs on Fibromuscular dysplasia differential diagnosis

Directions to Hospitals Treating Fibromuscular dysplasia

Risk calculators and risk factors for Fibromuscular dysplasia differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

  • There is a significant delay in diagnosis from the first onset of clinical symptoms/signs of 4.4 years in men and 4.1 years in women. There are several possible reasons for such a delay, including the possibility that FMD was not considered in the differential diagnosis of a patient’s symptoms because of under-recognition of this disorder, the mistaken belief that FMD is predominately a disease of young patients, and the fact that many of the signs and symptoms of FMD are nonspecific, such as dizziness, tinnitus, and headaches.

Differentiating X from other Diseases

Atherosclerosis usually involves the ostial or proximal segment of the arteries, whereas FMD involves the middle or distal segment. In addition, the "string of beads" appearance is unique to FMD. Thus, atherosclerotic disease and FMD can typically be distinguished radiographically.

  • There have been reports of Ehlers-Danlos Type IV being associated with medial fibroplasia. This should be suspected in patients who have multiple aneurysms in addition to the usual angiographic findings of FMD.

Ehlers-Danlos may occur in the absence of any prior bleeding manifestations. If this disease is suspected, a skin biopsy should be obtained and sent for fibroblast culture.

Large vessel vasculitis may occur in the absence of changes in acute phase reactants in up to 40% of cases. If histologic proof of FMD or inflammation is not available, distinguishing these entities may at times be difficult because the angiographic appearance can be similar, especially if the intimal fibroplasia is of the multivessel type.

  • Segmental arterial mediolysis is a poorly understood condition characterized by spontaneous dissection(s), occlusion, or aneurysm formation, which may be difficult to differentiate from FMD. Similar to FMD, segmental arterial mediolysis is a noninflammatory, nonatherosclerotic arterial disease. A definitive diagnosis of segmental arterial mediolysis requires tissue examination. This lesion of segmental arterial mediolysis is characterized by the vacuolar degeneration of smooth muscle cells.
  • Differential diagnosis of FMD Involving the [[[coronary arteries]], are cocaine vasculitis, coronary vasospasm, and atherosclerotic plaque.

other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

  • [Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].
  • As [disease namr e] manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].

Preferred Table

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3
Differential Diagnosis 1
Differential Diagnosis 2
Differential Diagnosis 3
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Differential Diagnosis 4
Differential Diagnosis 5
Differential Diagnosis 6

References

Template:WH Template:WS